MDxHealth to Present at the 2013 BIO CEO & Investor Conference
03:00 EST 4 Feb 2013 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
IRVINE, CA, and LIEGE, BELGIUM - February 4, 2013 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer diagnosis and treatment, today announced that Dr. Jan Groen ...
Other Sources for this Article
More From BioPortfolio on "MDxHealth to Present at the 2013 BIO CEO & Investor Conference"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
